Emvistegrast is an investigational new drug that as of 2026 was being developed by Gilead Sciences for the treatment of ulcerative colitis. It is an integrin alpha4/beta7 antagonist.
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.